Instil Bio financial statements

인스틸 바이오NASDAQ:TIL · Nasdaq · Healthcare · sector #16
$6.88-0.94%
2026-10-06 close · prelim

Instil Bio's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$74M.

Reported results

Instil Bio notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q